β-Arrestin 1 is required for endothelin-1-induced NF-κB activation in ovarian cancer cells

Roberta Cianfrocca, Piera Tocci, Elisa Semprucci, Francesca Spinella, Valeriana Di Castro, Anna Bagnato, Laura Rosanò

Research output: Contribution to journalArticle

Abstract

AIMS: In epithelial ovarian cancer (EOC), activation of endothelin-1 (ET-1)/endothelin A receptor (ETAR) signalling is linked to many tumor promoting effects, such as proliferation, angiogenesis, invasion and metastasis. These effects are dependent by the activation of critical signalling pathways, such as MAPK, Akt, and β-catenin, through specific cytosolic and nuclear scaffolding functions of β-arrestin 1 (β-arr1). Here, we have assessed the potential role of ET-1/ETAR in promoting NF-κB signalling in EOC cells through β-arr-1 recruitment.

MAIN METHODS: We used cultured HEY EOC cells cultured in the presence or absence of ET-1 and the ETAR antagonist BQ123. The phosphorylation of p65 and Iκ-Bα was evaluated by immunoblotting analysis. The interaction between p65 and β-arr1 was evaluated by immunoprecipitation experiments in nuclear extracts. NF-κB promoter activity was evaluated by transfection with NF-κB-driven luciferase reporter construct. Assessment of the function of β-arr1 was achieved by β-arr1 silencing with shRNA and expression of β-arr1-FLAG expression vector.

KEY FINDINGS: In EOC cells, ET-1 promotes the phosphorylation of p65 subunit and the cytoplasmic inhibitor IκB that in turn led to increased NF-κB transcriptional activity. These effects were inhibited by the use of BQ123, as well as by β-arr-1 silencing, suggesting that ET-1 through ETAR promotes the recruitment of β-arr1 to regulate NF-κB signalling. Moreover, the nuclear physical interaction between p65 and β-arr1 indicates a nuclear function of β-arr-1 in ETAR-driven NF-κB transcriptional activity.

SIGNIFICANCE: Altogether these findings reveal a previously unrecognized pathway that depends on β-arr1 to sustain NF-κB signalling in response to ETAR activation in ovarian cancer.

Original languageEnglish
Pages (from-to)179-184
Number of pages6
JournalLife Sciences
Volume118
Issue number2
DOIs
Publication statusPublished - Nov 24 2014

Fingerprint

Arrestin
Endothelin A Receptors
Endothelin-1
Ovarian Neoplasms
Chemical activation
Cells
Phosphorylation
Catenins
Critical Pathways
Luciferases
Immunoprecipitation
Immunoblotting
Small Interfering RNA
Transfection
Tumors
Cultured Cells
Neoplasm Metastasis
Ovarian epithelial cancer
Neoplasms
Experiments

Keywords

  • Endothelin-1
  • NF-κB
  • Ovarian cancer
  • β-Arrestin-1

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Cianfrocca, R., Tocci, P., Semprucci, E., Spinella, F., Di Castro, V., Bagnato, A., & Rosanò, L. (2014). β-Arrestin 1 is required for endothelin-1-induced NF-κB activation in ovarian cancer cells. Life Sciences, 118(2), 179-184. https://doi.org/10.1016/j.lfs.2014.01.078

β-Arrestin 1 is required for endothelin-1-induced NF-κB activation in ovarian cancer cells. / Cianfrocca, Roberta; Tocci, Piera; Semprucci, Elisa; Spinella, Francesca; Di Castro, Valeriana; Bagnato, Anna; Rosanò, Laura.

In: Life Sciences, Vol. 118, No. 2, 24.11.2014, p. 179-184.

Research output: Contribution to journalArticle

Cianfrocca, R, Tocci, P, Semprucci, E, Spinella, F, Di Castro, V, Bagnato, A & Rosanò, L 2014, 'β-Arrestin 1 is required for endothelin-1-induced NF-κB activation in ovarian cancer cells', Life Sciences, vol. 118, no. 2, pp. 179-184. https://doi.org/10.1016/j.lfs.2014.01.078
Cianfrocca, Roberta ; Tocci, Piera ; Semprucci, Elisa ; Spinella, Francesca ; Di Castro, Valeriana ; Bagnato, Anna ; Rosanò, Laura. / β-Arrestin 1 is required for endothelin-1-induced NF-κB activation in ovarian cancer cells. In: Life Sciences. 2014 ; Vol. 118, No. 2. pp. 179-184.
@article{137b8c756ca14675a87d44db0fda43e7,
title = "β-Arrestin 1 is required for endothelin-1-induced NF-κB activation in ovarian cancer cells",
abstract = "AIMS: In epithelial ovarian cancer (EOC), activation of endothelin-1 (ET-1)/endothelin A receptor (ETAR) signalling is linked to many tumor promoting effects, such as proliferation, angiogenesis, invasion and metastasis. These effects are dependent by the activation of critical signalling pathways, such as MAPK, Akt, and β-catenin, through specific cytosolic and nuclear scaffolding functions of β-arrestin 1 (β-arr1). Here, we have assessed the potential role of ET-1/ETAR in promoting NF-κB signalling in EOC cells through β-arr-1 recruitment.MAIN METHODS: We used cultured HEY EOC cells cultured in the presence or absence of ET-1 and the ETAR antagonist BQ123. The phosphorylation of p65 and Iκ-Bα was evaluated by immunoblotting analysis. The interaction between p65 and β-arr1 was evaluated by immunoprecipitation experiments in nuclear extracts. NF-κB promoter activity was evaluated by transfection with NF-κB-driven luciferase reporter construct. Assessment of the function of β-arr1 was achieved by β-arr1 silencing with shRNA and expression of β-arr1-FLAG expression vector.KEY FINDINGS: In EOC cells, ET-1 promotes the phosphorylation of p65 subunit and the cytoplasmic inhibitor IκB that in turn led to increased NF-κB transcriptional activity. These effects were inhibited by the use of BQ123, as well as by β-arr-1 silencing, suggesting that ET-1 through ETAR promotes the recruitment of β-arr1 to regulate NF-κB signalling. Moreover, the nuclear physical interaction between p65 and β-arr1 indicates a nuclear function of β-arr-1 in ETAR-driven NF-κB transcriptional activity.SIGNIFICANCE: Altogether these findings reveal a previously unrecognized pathway that depends on β-arr1 to sustain NF-κB signalling in response to ETAR activation in ovarian cancer.",
keywords = "Endothelin-1, NF-κB, Ovarian cancer, β-Arrestin-1",
author = "Roberta Cianfrocca and Piera Tocci and Elisa Semprucci and Francesca Spinella and {Di Castro}, Valeriana and Anna Bagnato and Laura Rosan{\`o}",
year = "2014",
month = "11",
day = "24",
doi = "10.1016/j.lfs.2014.01.078",
language = "English",
volume = "118",
pages = "179--184",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - β-Arrestin 1 is required for endothelin-1-induced NF-κB activation in ovarian cancer cells

AU - Cianfrocca, Roberta

AU - Tocci, Piera

AU - Semprucci, Elisa

AU - Spinella, Francesca

AU - Di Castro, Valeriana

AU - Bagnato, Anna

AU - Rosanò, Laura

PY - 2014/11/24

Y1 - 2014/11/24

N2 - AIMS: In epithelial ovarian cancer (EOC), activation of endothelin-1 (ET-1)/endothelin A receptor (ETAR) signalling is linked to many tumor promoting effects, such as proliferation, angiogenesis, invasion and metastasis. These effects are dependent by the activation of critical signalling pathways, such as MAPK, Akt, and β-catenin, through specific cytosolic and nuclear scaffolding functions of β-arrestin 1 (β-arr1). Here, we have assessed the potential role of ET-1/ETAR in promoting NF-κB signalling in EOC cells through β-arr-1 recruitment.MAIN METHODS: We used cultured HEY EOC cells cultured in the presence or absence of ET-1 and the ETAR antagonist BQ123. The phosphorylation of p65 and Iκ-Bα was evaluated by immunoblotting analysis. The interaction between p65 and β-arr1 was evaluated by immunoprecipitation experiments in nuclear extracts. NF-κB promoter activity was evaluated by transfection with NF-κB-driven luciferase reporter construct. Assessment of the function of β-arr1 was achieved by β-arr1 silencing with shRNA and expression of β-arr1-FLAG expression vector.KEY FINDINGS: In EOC cells, ET-1 promotes the phosphorylation of p65 subunit and the cytoplasmic inhibitor IκB that in turn led to increased NF-κB transcriptional activity. These effects were inhibited by the use of BQ123, as well as by β-arr-1 silencing, suggesting that ET-1 through ETAR promotes the recruitment of β-arr1 to regulate NF-κB signalling. Moreover, the nuclear physical interaction between p65 and β-arr1 indicates a nuclear function of β-arr-1 in ETAR-driven NF-κB transcriptional activity.SIGNIFICANCE: Altogether these findings reveal a previously unrecognized pathway that depends on β-arr1 to sustain NF-κB signalling in response to ETAR activation in ovarian cancer.

AB - AIMS: In epithelial ovarian cancer (EOC), activation of endothelin-1 (ET-1)/endothelin A receptor (ETAR) signalling is linked to many tumor promoting effects, such as proliferation, angiogenesis, invasion and metastasis. These effects are dependent by the activation of critical signalling pathways, such as MAPK, Akt, and β-catenin, through specific cytosolic and nuclear scaffolding functions of β-arrestin 1 (β-arr1). Here, we have assessed the potential role of ET-1/ETAR in promoting NF-κB signalling in EOC cells through β-arr-1 recruitment.MAIN METHODS: We used cultured HEY EOC cells cultured in the presence or absence of ET-1 and the ETAR antagonist BQ123. The phosphorylation of p65 and Iκ-Bα was evaluated by immunoblotting analysis. The interaction between p65 and β-arr1 was evaluated by immunoprecipitation experiments in nuclear extracts. NF-κB promoter activity was evaluated by transfection with NF-κB-driven luciferase reporter construct. Assessment of the function of β-arr1 was achieved by β-arr1 silencing with shRNA and expression of β-arr1-FLAG expression vector.KEY FINDINGS: In EOC cells, ET-1 promotes the phosphorylation of p65 subunit and the cytoplasmic inhibitor IκB that in turn led to increased NF-κB transcriptional activity. These effects were inhibited by the use of BQ123, as well as by β-arr-1 silencing, suggesting that ET-1 through ETAR promotes the recruitment of β-arr1 to regulate NF-κB signalling. Moreover, the nuclear physical interaction between p65 and β-arr1 indicates a nuclear function of β-arr-1 in ETAR-driven NF-κB transcriptional activity.SIGNIFICANCE: Altogether these findings reveal a previously unrecognized pathway that depends on β-arr1 to sustain NF-κB signalling in response to ETAR activation in ovarian cancer.

KW - Endothelin-1

KW - NF-κB

KW - Ovarian cancer

KW - β-Arrestin-1

UR - http://www.scopus.com/inward/record.url?scp=84942617254&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942617254&partnerID=8YFLogxK

U2 - 10.1016/j.lfs.2014.01.078

DO - 10.1016/j.lfs.2014.01.078

M3 - Article

C2 - 24530737

AN - SCOPUS:84894528689

VL - 118

SP - 179

EP - 184

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 2

ER -